We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03924401
Recruitment Status : Recruiting
First Posted : April 23, 2019
Last Update Posted : March 18, 2022
Thrasher Research Fund
Sickle Cell Transplant Advocacy & Research Alliance (STAR)
Aflac Cancer and Blood Disorders Center
Bristol-Myers Squibb
Information provided by (Responsible Party):
John Horan, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023